- Home
- CHEC vs HRTX Comparison
CHEC vs HRTX Comparison
Compare CHEC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
HOLD
Current Price
$1.37
Company Overview
Basic Information| Metric | CHEC | HRTX |
|---|---|---|
| Founded | 2024 | 1983 |
| Country | Singapore | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.7M | 203.5M |
| IPO Year | 2025 | 1987 |
Fundamental Metrics
Financial Performance| Metric | CHEC | HRTX |
|---|---|---|
| Price | $9.97 | $1.37 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $4.50 |
| AVG Volume (30 Days) | 93.4K | ★ 2.1M |
| Earning Date | 01-01-0001 | 11-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $155,097,000.00 |
| Revenue This Year | N/A | $8.98 |
| Revenue Next Year | N/A | $11.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 12.60 |
| 52 Week Low | $9.91 | $1.00 |
| 52 Week High | $10.56 | $2.68 |
Technical Indicators
Market Signals| Indicator | CHEC | HRTX |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 69.56 |
| Support Level | N/A | $1.10 |
| Resistance Level | N/A | $1.37 |
| Average True Range (ATR) | 0.00 | 0.07 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 91.43 |
Price Performance
Historical Comparison CHEC
HRTX
About CHEC Chenghe Acquisition III Co. Class A Ordinary Share
Chenghe Acquisition III Co is blank check company.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.